0 Comentários
0 Compartilhamentos
2KB Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
VEGF-B Inhibitors Market Gains Traction with Advances in Cardiovascular and Oncology Research"Executive Summary VEGF-B Inhibitors Market Size, Share, and Competitive Landscape CAGR Value Global VEGF-B inhibitors market size was valued at USD 1.27 Billion in 2024 and is projected to reach USD 3.75 billion by 2032, with a CAGR of 14.4% during the forecast period of 2025 to 2032. An exceptional VEGF-B Inhibitors Market research document can be formulated well with the blend of top...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Comentários 0 Compartilhamentos 301 Visualizações 0 Anterior
-
Clinical Oncology Next Generation Sequencing Market Market Size, Top Industry Players and Forecast to 2033Clinical Oncology Next Generation Sequencing Industry Outlook: Straits Research has added a report titled “Global Clinical Oncology Next Generation Sequencing Market Professional Report 2025-2033” to its database of research reports. The study provides complete details about the usage and adoption of Clinical Oncology Next Generation Sequencing in various industrial applications...0 Comentários 0 Compartilhamentos 626 Visualizações 0 Anterior
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Future Market Potential of Chemotherapy-Induced Peripheral Neuropathy TreatmentsThe global chemotherapy-induced peripheral neuropathy market size is projected to grow from US$ 1.01 billion in 2025 to approximately US$ 1.67 billion by 2034, reflecting a steady expansion. The market is anticipated to register a compound annual growth rate (CAGR) of around 5.71% during the forecast period, highlighting increasing investments in oncology supportive care. The...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
Global CAR-T Cell Therapy Market Growth at 17.5% CAGR Through 2030Increasing research and development activities in cell-based therapies are supporting the expansion of the CAR-T cell therapy market. Pharmaceutical and biotechnology companies are investing heavily in clinical trials and advanced technologies. These efforts are accelerating the development of new and effective cancer treatments. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
How the Prostate Cancer Diagnostics Market Is Advancing with AI and Biomarker-Based Screening?Executive Summary Prostate Cancer Diagnostics Market: Growth Trends and Share Breakdown CAGR Value The global prostate cancer diagnostics market size was valued at USD 4.63 billion in 2024 and is expected to reach USD 10.31 billion by 2032, at a CAGR of 10.50% during the forecast period Prostate Cancer Diagnostics Market research report is a verified source of data and information that...0 Comentários 0 Compartilhamentos 5KB Visualizações 0 Anterior
-
Immunotherapy Impact on the Anti-cancer Drugs MarketThe rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comentários 0 Compartilhamentos 245 Visualizações 0 Anterior
-
Why the Azacitidine Market Holds Promise for Advanced Cancer and Blood Disorder Treatments?Executive Summary Azacitidine Market: Share, Size & Strategic Insights CAGR Value The global azacitidine market was valued at USD 90.24 billion in 2024 and is expected to reach USD 165.79 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.90%, primarily driven by increasing geriatric population Azacitidine Market report is...0 Comentários 0 Compartilhamentos 3KB Visualizações 0 Anterior
Páginas impulsionada